From the Departments of Interventional Radiology (Y.M.L., I.P., B.C.O.), Imaging Physics (C.S.O., B.M.A., B.R., K.A.J., K.K.B.), and Biostatistics (B.M.F.), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.
Radiology. 2023 Apr;307(2):e221373. doi: 10.1148/radiol.221373. Epub 2023 Jan 31.
Background Confirming ablation completeness with sufficient ablative margin is critical for local tumor control following colorectal liver metastasis (CLM) ablation. An image-based confirmation method considering patient- and ablation-related biomechanical deformation is an unmet need. Purpose To evaluate a biomechanical deformable image registration (DIR) method for three-dimensional (3D) minimal ablative margin (MAM) quantification and the association with local disease progression following CT-guided CLM ablation. Materials and Methods This single-institution retrospective study included patients with CLM treated with CT-guided microwave or radiofrequency ablation from October 2015 to March 2020. A biomechanical DIR method with AI-based autosegmentation of liver, tumors, and ablation zones on CT images was applied for MAM quantification retrospectively. The per-tumor incidence of local disease progression was defined as residual tumor or local tumor progression. Factors associated with local disease progression were evaluated using the multivariable Fine-Gray subdistribution hazard model. Local disease progression sites were spatially localized with the tissue at risk for tumor progression (<5 mm) using a 3D ray-tracing method. Results Overall, 213 ablated CLMs (mean diameter, 1.4 cm) in 124 consecutive patients (mean age, 57 years ± 12 [SD]; 69 women) were evaluated, with a median follow-up interval of 25.8 months. In ablated CLMs, an MAM of 0 mm was depicted in 14.6% (31 of 213), from greater than 0 to less than 5 mm in 40.4% (86 of 213), and greater than or equal to 5 mm in 45.1% (96 of 213). The 2-year cumulative incidence of local disease progression was 72% for 0 mm and 12% for greater than 0 to less than 5 mm. No local disease progression was observed for an MAM greater than or equal to 5 mm. Among 117 tumors with an MAM less than 5 mm, 36 had local disease progression and 30 were spatially localized within the tissue at risk for tumor progression. On multivariable analysis, an MAM of 0 mm (subdistribution hazard ratio, 23.3; 95% CI: 10.8, 50.5; < .001) was independently associated with local disease progression. Conclusion Biomechanical deformable image registration and autosegmentation on CT images enabled identification and spatial localization of colorectal liver metastases at risk for local disease progression following ablation, with a minimal ablative margin greater than or equal to 5 mm as the optimal end point. © RSNA, 2023 See also the editorial by Sofocleous in this issue.
背景 确认结直肠肝转移 (CLM) 消融后的消融完整性并保证充足的消融边界对于局部肿瘤控制至关重要。目前仍需要一种基于图像的确认方法,以考虑患者和消融相关的生物力学变形。
目的 评估一种基于生物力学的三维 (3D) 最小消融边界 (MAM) 量化形变图像配准 (DIR) 方法,并评估其与 CT 引导下 CLM 消融后局部疾病进展的相关性。
材料与方法 该单中心回顾性研究纳入了 2015 年 10 月至 2020 年 3 月接受 CT 引导下微波或射频消融治疗的 CLM 患者。应用基于人工智能的自动分割肝脏、肿瘤和消融区的生物力学 DIR 方法对 CT 图像进行回顾性 MAM 量化。以残留肿瘤或局部肿瘤进展为局部疾病进展的肿瘤发生率定义。采用多变量 Fine-Gray 亚分布风险模型评估与局部疾病进展相关的因素。采用三维射线追踪方法,用肿瘤进展风险组织(<5 mm)对局部疾病进展部位进行空间定位。
结果 共评估了 124 例连续患者(平均年龄,57 岁±12 [标准差];69 例女性)中 213 个消融后的 CLM(平均直径,1.4 cm),中位随访时间为 25.8 个月。在消融后的 CLM 中,14.6%(31/213)的 MAM 为 0 mm,40.4%(86/213)的 MAM 为 0<5 mm,45.1%(96/213)的 MAM 为≥5 mm。0 mm 组的 2 年局部疾病进展累积发生率为 72%,0<5 mm 组的为 12%。MAM≥5 mm 组未见局部疾病进展。在 117 个 MAM<5 mm 的肿瘤中,36 个发生了局部疾病进展,30 个肿瘤位于肿瘤进展风险组织内。多变量分析显示,MAM 为 0 mm(亚分布风险比,23.3;95%CI:10.8,50.5;<.001)与局部疾病进展独立相关。
结论 基于 CT 图像的生物力学形变图像配准和自动分割,能够识别并对消融后有发生局部疾病进展风险的结直肠肝转移进行空间定位,MAM≥5 mm 是最佳终点。